| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2023―Feb―18 |
Activation of the interferon pathway in trophoblast cells productively infected with SARS-CoV-2 |
Sampada Kallol, Laura Martin-Sancho, Robert Morey, Omonigho Aisagbonhi, Donald Pizzo, Morgan Meads, et al. (+2) Sumit K Chanda, Francesca Soncin |
| 2 |
[GO] |
2021―Aug―21 |
Research status of the safety and efficacy of mesenchymal stem cells in the treatment of COVID-19-related pneumonia: A systematic review and meta-analysis |
Junwu Wang, Pengzhi Shi, Dong Chen, Shuguang Wang, Pingchuan Wang, Xinmin Feng, liang zhang |
| 3 |
[GO] |
2021―Jun―02 |
Wharton’s Jelly Mesenchymal Stem Cell-derived Extracellular Vesicles Reduce SARS-CoV2 Induced Inflammatory Cytokines under High Glucose and Uremic Toxin Conditions |
Vuong Cat Khanh, Mizuho Fukushige, Yun-Hsuan Chang, Ngo Nhat Hoang, Toshiharu Yamashita, Mana Obata-Yasuoka, et al. (+4) Hiromi Hamada, Motoo Osaka, Yuji Hiramatsu, Osamu Ohneda |
| 4 |
[GO] |
2021―Mai―28 |
Human umbilical cord mesenchymal stromal cell treatment of severe COVID-19 patients: a three-month follow-up study following hospital discharge |
Ganzhu Feng, Lei Shi, Tingrong Huang, Ningfei Ji, You Zheng, Huan Lin, et al. (+12) Changming Niu, Yan Wang, Ruyou Li, Mao Huang, Xiaolin Chen, Lei Shu, Mingjing Wu, Kaili Deng, Jing Wei, Xueli Wang, Yang Cao, Jiaxin Yan |
| 5 |
[GO] |
2021―Mrz―15 |
Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19 |
Qiqi Cai, Fei Yin, Liming Hao, Wen-Hua Jiang |
| 6 |
[GO] |
2020―Dez―14 |
The coronavirus pandemic: a pitfall or a fast-track for validating cell therapy products? |
maroun khoury, Laertis Ikonomou, massimo Dominici, Katarina Le Blanc, Bruce L Levine, Dan J Weiss |
| 7 |
[GO] |
2020―Sep―01 |
Human induced pluripotent stem cell-derived lung epithelial system for SARS-CoV-2 infection modeling and its potential in drug repurposing |
Harshini Surendran, Swapna Nandakumar, Rajarshi Pal |
| 8 |
[GO] |
2020―Jun―10 |
Response to Kim et al. re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19” |
Vikram Sengupta, Sascha Sengupta, Angel Lazo, Kevin C. Hicok, Timothy Moseley |
| 9 |
[GO] |
2020―Jun―10 |
Re: “Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19” by Sengupta et al. |
Sai Kiang Lim, Bernd Giebel, Daniel J. Weiss, Kenneth W. Witwer, Eva Rohde |
| 10 |
[GO] |
2020―Mai―08 |
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19 |
Vikram Sengupta, Sascha Sengupta, Angel Lazo, Peter Woods, Anna Nolan, Nicholas Bremer |
| 11 |
[GO] |
2020―Apr―15 |
Stem cell-based therapy for coronavirus disease 2019 |
Robert Chunhua Zhao |
| 12 |
[GO] |
2020―Apr―02 |
Impact of COVID-19 and Future Emerging Viruses on Hematopoietic Cell Transplantation and Other Cellular Therapies |
Hal E. Broxmeyer, Graham C. Parker |
|
